KATHRYN ENTREKIN: Open Payments
NPI 1093346470 · CARROLLTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$688 in 53 payments from 9 companies in 2025. Trend: 2023 $655 · 2024 $686 · 2025 $688
Food & beverage: $688
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $234 |
| Axsome Therapeutics, Inc. | 6 | $126 |
| Teva Pharmaceuticals USA, Inc. | 5 | $88 |
| Otsuka America Pharmaceutical, Inc. | 3 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $52 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $51 |
| Neurocrine BioSciences, Inc. | 2 | $43 |
| Alkermes, Inc. | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
Products named: VRAYLAR, Auvelity, AUSTEDO XR, TRINTELLIX, CAPLYTA, INGREZZA, REXULTI, ARISTADA.
Industry payments across GA — which companies pay providers there.
